Cyrille Tupin

CEO

Chief Executive Officer

FR·AMF

Abionyx Pharma

Total declarations

Company

▲ Purchases (1 ops.)

€9,487

▼ Sales (0 ops.)

—

Latest filing published 01 Sept 2026 for Abionyx Pharma. Read the official filing

Filing timeline

BuySale

Cyrille Tupin

Insider track record

Disclosed buys

Disclosed sells

Signal history

Closed purchases

Market purchases

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Abionyx Pharma 1 purchase · last 14 Mar 2022

Since each purchase

Abionyx Pharma
Filed 14 Mar 2022 · 1678 days ago · €9,487
-0.2%
Entry €1.89 · Close at T+365 €1.88

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Cyrille Tupin: trading record in brief

All filings by Cyrille Tupin on record concern Abionyx Pharma, in the capacity of chief executive. Between 3 December 2021 and 24 August 2026, the trades on record add up to 7 filings.

The open-market record is one-sided, with 1 purchase worth €9,487 and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 5 share grants.

On 1 September 2026 came the latest disclosure, a share grant in Abionyx Pharma. The last purchase on record was published on 14 March 2022, which is 1,678 days ago. Between a trade and the moment it shows up on AMF, the median delay is 3 days. The regulation allows three business days to notify a trade (MAR article 19). Source: insider filings from AMF. Past trades are no guide to future returns.